Latest news
CEL-SCI Study Published in Peer-Reviewed Oral Oncology Supports Multikine's Biomarker Strategy and Potential Overall Survival Benefit Ahead of Head and Neck Cancer Confirmatory Registration Study - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 12:00:00 GMTLeading Oncology Journal Accepts For Publication New CEL-SCI Multikine Phase 3 Data Demonstrating Overall Survival Benefit in Underserved Head and Neck Cancer Patients - Business WireBusiness Wire · Thu, 30 Jul 2026 12:31:00 GMT